Lyell Immunopharma, Inc. — Form D

Lyell Immunopharma, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-20. The offering totals $493.0M, of which $493.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2020-03-20
Form: D
Accession: 0001806952-20-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $493.0M
Amount sold: $493.0M
Investors: 10
Date of first sale: 2020-03-05
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-363351

Issuer

Name: Lyell Immunopharma, Inc.
CIK: 0001806952
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 400 EAST JAMIE COURT, SOUTH SAN FRANCISCO, CA, 94080
Phone: 650 695-0677

Officers, directors & promoters (13)

Name	Role	Location
HANS BISHOP	Director	MENLO PARK, CA
CATHERINE FRIEDMAN	Director	MENLO PARK, CA
Richard Klausner	Director	South San Francisco, CA
Robert Nelson	Director	Shreveport, LA
Richard Goold	Executive Officer	South San Francisco, CA
Stephen Hill	Executive Officer	Lake Forest, IL
Elizabeth Homans	Executive Officer	Baltimore, MD
Richard Klausner	Executive Officer	South San Francisco, CA
Nicholas Restifo	Executive Officer	South San Francisco, CA
Stan Riddell	Executive Officer	South San Francisco, CA
Margo Roberts	Executive Officer	South San Francisco, CA
Heather Turner	Executive Officer	South San Francisco, CA
Richard Klausner	Promoter	South San Francisco, CA

More